An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol. - P A Costa G; Sofuoglu M; Compton P; Ranganathan M; Pittman B; De Aquino JP (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026)